Discontinuation of imatinib therapy after achieving a molecular response [3]

Jorge Cortes; Susan O'Brien; Hagop Kantarjian

doi:10.1182/blood-2004-04-1335

Discontinuation of imatinib therapy after achieving a molecular response [3]

Jorge Cortes, Susan O'Brien, Hagop Kantarjian

Research output: Contribution to journal › Letter › peer-review

Original language	English (US)
Pages (from-to)	2204-2205
Number of pages	2
Journal	Blood
Volume	104
Issue number	7
DOIs	https://doi.org/10.1182/blood-2004-04-1335
State	Published - Oct 1 2004
Externally published	Yes

ASJC Scopus subject areas

Biochemistry
Immunology
Hematology
Cell Biology

Access to Document

10.1182/blood-2004-04-1335

Cite this

@article{7f4ea76f51734b6ba56fc9874c07ae5e,

title = "Discontinuation of imatinib therapy after achieving a molecular response [3]",

author = "Jorge Cortes and Susan O'Brien and Hagop Kantarjian",

year = "2004",

month = oct,

day = "1",

doi = "10.1182/blood-2004-04-1335",

language = "English (US)",

volume = "104",

pages = "2204--2205",

journal = "Blood",

issn = "0006-4971",

publisher = "American Society of Hematology",

number = "7",

}

TY - JOUR

T1 - Discontinuation of imatinib therapy after achieving a molecular response [3]

AU - Cortes, Jorge

AU - O'Brien, Susan

AU - Kantarjian, Hagop

PY - 2004/10/1

Y1 - 2004/10/1

UR - http://www.scopus.com/inward/record.url?scp=4644341516&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=4644341516&partnerID=8YFLogxK

U2 - 10.1182/blood-2004-04-1335

DO - 10.1182/blood-2004-04-1335

M3 - Letter

C2 - 15377577

AN - SCOPUS:4644341516

SN - 0006-4971

VL - 104

SP - 2204

EP - 2205

JO - Blood

JF - Blood

IS - 7

ER -

Discontinuation of imatinib therapy after achieving a molecular response [3]

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this